AI assistant
Sending…
RESMED INC — Director's Dealing 2023
Oct 4, 2023
30071_dirs_2023-10-04_eee70aba-7d3b-4ced-8f4a-a2c1781f0334.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2023-10-02
Reporting Person: Rider Michael J (Global General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-10-02 | ResMed Common Stock | S | 25 | $145.92 | Disposed | 7383 | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan adopted February 24, 2023.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29